Crossref
Mass Production and Characterization of Recombinant Human Grim-19 in Escherichia coli
Drug Targets and Therapeutics · 2023
DOI: 10.58502/dtt.23.0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2023. Verfasst von Gaurab Subedi und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Research Foundation of Korea, Gachon University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Foundation of Korea
- Gachon University
Zitieren
APA
Subedi, G., & Park, S. J. (2023). Mass Production and Characterization of Recombinant Human Grim-19 in Escherichia coli. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.23.0013
Vancouver
Subedi G, Park SJ. Mass Production and Characterization of Recombinant Human Grim-19 in Escherichia coli. Drug Targets and Therapeutics. 2023. doi:10.58502/dtt.23.0013
BibTeX
@article{Subedi2023,
author = {Subedi, Gaurab and Park, Sung Jean},
title = {Mass Production and Characterization of Recombinant Human Grim-19 in Escherichia coli},
journal = {Drug Targets and Therapeutics},
year = {2023},
doi = {10.58502/dtt.23.0013}
}
EUVIMED